The current treatment of Alzheimer’s disease includes the use of cholinesterase inhibitors (CIs) for mild to moderate symptoms and memantine, an N-methyl-D-aspartate (NMDA) receptor antagonist, for moderate to severe AD symptoms. The gene discussed is BCHE; the disease is Alzheimer disease.